Oberdiessbach, Switzerland – Hoffmann Neopac, a global provider of high-quality packaging for a broad array of industries and applications, has developed a differentiating packaging solution for a topical antiparasitic solution produced by Aurora Pharmaceuticals, Inc., a US-based manufacturer and distributer of animal health medicines. Featuring the active ingredient selamectin, the recently released Revolt™ Topical Solution is now available via prescription in convenient, high-barrier single-use tubes with a simple, no-mess applicator.
For the project, Neopac produced its Twist’n’use™ tube, a small-volume single-dose solution that, once the cap is twisted, is irrevocably opened. In addition to tamper-evidence, the tube’s permanently affixed cap emphasizes consumer simplicity and offers accurate application of the enclosed product to the area of treatment.
For Aurora Pharmaceuticals, it was important that Revolt™ be packaged in a solution that optimized aesthetics without necessitating an external moisture barrier. Meeting this need, the Twist’n’use™ tube features Neopac’s Polyfoil® technology – a proprietary blend of materials providing advanced barrier properties for products requiring ample protection against moisture, oxygen and other potentially harmful substances. Products housed in Polyfoil® solutions can enjoy a longer shelf life compared to those stored in conventional polyethylene (PE) or polypropylene (PP) packaging.
Revolt™ Topical Solution comes in a variety of sizes and strengths, coinciding with the size of the dog or cat receiving it. Versions with 6% API are available in .25ml, .75ml and 1ml tubes, while 12% API is available in .5ml, 1ml, 2ml or 3ml tubes. Neopac’s Twist’n’use™ tubes can hold volumes up to 10ml.
There were some challenges during the partnership, including a chemical compatibility issue, but Neopac’s technical team was able to support and overcome these challenges for a smooth and successful launch.
Thus far, feedback from customers who’ve used Revolt™ has been overwhelmingly positive, with users pointing to its convenient ease of use and attractive brand aesthetics.
“Neopac was the only packaging partner that could offer our sought-after combination of premium barrier protection, small-dose delivery accuracy, chemical compatibility, and overall manufacturing quality,” said Richard Mihalik, Director of R&D / Business Development for Aurora Pharmaceuticals, Inc. “We are especially thrilled with the innovative dispensing design, which provides direct, hassle-free application of a product that would be otherwise cumbersome to apply.”
For the animal health sector, Aurora Pharmaceuticals specializes in developing and manufacturing liquid dosage products in volumes as small as 0.23 mL to as large as 20L. Revolt™ Topical Solution represents the company’s first single-dose topical pharmaceutical approval and launch.
Hoffmann Neopac AG
If you would like to know more – current announcements regarding Neopac's parent company.